Trials / Conditions / Preeclampsia Severe

Preeclampsia Severe

24 registered clinical trials studyying Preeclampsia Severe — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Biomarkers in Management of Post Partum Preeclampsia NCT07478055	Alexander Harrison	Phase 4
Completed	Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia NCT06712550	SHAHLA KAREEM ALALAF	—
Active Not Recruiting	Preeclampsia Educational Program Study (PrEPS) NCT06373367	MemorialCare Health System	N/A
Recruiting	Intravenous Labetalol Versus Hydralazine in Preeclampsia NCT06360601	Tanta University	Phase 1 / Phase 2
Completed	Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomid NCT05610774	Benha University	N/A
Unknown	Metformin and Esomeprazole For Preterm Pre-eclampsia NCT05232994	Christiana Care Health Services	Phase 1
Recruiting	LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention NCT07361679	Alexandra Hospital, Athens, Greece	Phase 4
Completed	Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Pr NCT05594056	Saint Thomas Hospital, Panama	N/A
Unknown	Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial NCT04855513	Hamad Medical Corporation	N/A
Completed	The Use of Eculizumab in HELLP Syndrome NCT04103489	Johns Hopkins University	Phase 1
Unknown	Risk Prediction Model of Preeclampsia NCT04794855	Peking University Third Hospital	—
Terminated	Metformin and Esomeprazole in Preterm Pre-eclampsia NCT06359015	Christiana Care Health Services	Phase 4
Completed	Nudge to Drive Transitions of Care NCT04660032	University of Pennsylvania	N/A
Terminated	Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC) NCT04243278	Dr. Graeme Smith	EARLY_Phase 1
Completed	Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor NCT04392375	Ohio State University	Phase 4
Completed	Expanded NIPT for Pregnancy Complications NCT04311749	University of California, San Francisco	—
Completed	Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period NCT04236258	Brigham and Women's Hospital	Phase 4
Completed	Uterotonics for Severe Preeclampsia NCT04756661	Assiut University	N/A
Completed	Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial NCT03978767	Washington University School of Medicine	Phase 2
Completed	Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification NCT03815110	Cedars-Sinai Medical Center	—
Unknown	Nicardipine and Labetalol Effects on Cerebral Hemodynamics in Preeclampsia NCT03761888	Hopital Antoine Beclere	—
Completed	Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclamps NCT03451266	University Medical Centre Ljubljana	Phase 1
Unknown	Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled NCT03318211	Cairo University	Phase 4
Completed	Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients NCT03210350	Corniche Hospital	—